Seeking Alpha

AEterna Zentaris (AEZS) -16.6% premarket after the drug development company said it commenced a...

AEterna Zentaris (AEZS) -16.6% premarket after the drug development company said it commenced a public offering of units consisting of common shares and warrants to purchase common shares. The size of the offering was not disclosed.
Comments (5)
  • So they are raping longs with big dilution, after April disaster and after reverse split like 5 days ago. What an investment.. just wow!
    12 Oct 2012, 08:24 AM Reply Like
  • What is needed is to vote the existing management OUT & have a new proactive shrewdest Management in place. We do not needed professors, doctors or scientist to run this company. Those should be relegated to Research & Development....

     

    Engel: ...... Out.... Before the company goes bankrupt
    BODs: .......Out....

     

    I rest my case
    12 Oct 2012, 08:52 AM Reply Like
  • Should companies like this one ever IPO? (No) Spec biotech is a lottery ticket on most bets. (Sad but true) Insiders always win this lottery.
    12 Oct 2012, 11:03 AM Reply Like
  • Roth Capital initiates the stock at a Buy last month. This month they are the sole book runner for this offering slamming anyone who made a buy on their coverage initiation.
    12 Oct 2012, 01:27 PM Reply Like
  • What can we, AEZS investors, do to change Company's direction from going under??? Swim to shore rather than sink!!!!!!
    14 Oct 2012, 07:34 AM Reply Like
DJIA (DIA) S&P 500 (SPY)